KMCSHIL vs PAR: Stock Comparison
K M C SPECIALITY HOSP I L shows faster revenue growth, while PAR shows a lower P/E and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
KMCSHIL leads 2; PAR leads 6 of 9
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | KMCSHIL | PAR |
|---|---|---|
| Sector | — | Healthcare |
| Industry | — | Pharmaceuticals |
Price
| Metric | KMCSHIL | PAR |
|---|---|---|
| Live Price | ₹155.58 | ₹164.95 |
| Day Change | 5.89% | -1.96% |
| Volume | 44.74 L | 7.26 L |
| 52-Week High | ₹154 | ₹180 |
| 52-Week Low | ₹128.48 | ₹78.05 |
| Distance from 52W High | 1.03% | -8.36% |
Valuation
| Metric | KMCSHIL | PAR |
|---|---|---|
| Market Cap | ₹0 Cr | ₹163 Cr |
| P/E Ratio | 40.39x | 8.55x |
| P/B Ratio | 10.71x | 0x |
| EPS | ₹1.02 | ₹3.83 |
| Book Value | ₹12.9 | ₹91.01 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | KMCSHIL | PAR |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | -12.2% |
| EPS Growth (TTM YoY) | 0% | -48.5% |
| Qtr Sales Growth | -69.98% | 59.51% |
| Qtr Profit Growth | -64.54% | 452.1% |
Profitability & Leverage
| Metric | KMCSHIL | PAR |
|---|---|---|
| ROE | — | 11.71% |
| ROCE | — | 18.83% |
| Net Margin | 0% | 12.65% |
| Operating Margin | — | 16.81% |
| Debt to Equity | — | 0x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | KMCSHIL | PAR |
|---|---|---|
| Promoter Holding | 75% | 73.41% |
| FII Holding | 0.02%▲ 0.02 pp | 0% |
| DII Holding | 0% | 0.09%▲ 0.09 pp |
| Public Holding | 24.98%▼ 0.02 pp | 26.51%▼ 0.08 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: K M C SPECIALITY HOSP I L and PAR.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.